RTTNews | Oct 26, 2020 09:57AM EDT

09:56 Monday, October 26, 2020 (RTTNews.com) - Mirati Therapeutics, Inc. (MRTX) shares are rising on Monday morning trade as the clinical-stage oncology company presented deep and durable anti-tumor activity for Adagrasib in non-small cell lung cancer, colorectal cancer, and other solid tumors.

Currently, the shares are at $210.46, up 15.12 percent from its previous close of $180.20.

The shares have traded in a range of $66.01 to $210.00 on average volume of 418,534.

Read the original article on RTTNews ( https://www.rttnews.com/3139186/stock-alert-mirati-up-15-on-positive-outcome-for-its-adagrasib.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved